More Latest News
-
Bonds with a contractually guaranteed coupon are a prudent way of generating income in 2021
Phil Milburn, Global Fixed Income Team for Liontrust The anticipated economic recovery in 2021 will provide a strong tailwind for most companies’…
-
Ongoing improvement in healthcare is vital for a more sustainable future
Peter Michaelis, Sustainable Investment Team for Liontrust Pharmaceutical companies are clearly at the centre of public attention at present, with news on…
-
2020 showed how resilient and adaptable listed businesses can be
Victoria Stevens, Economic Advantage Team for Liontrust The Covid-19 crisis led to some companies needing to raise funds quickly to tackle the…
-
Wednesday preview: US Presidential inauguration, Dixons Carphone in focus
(Sharecast News) – Financial markets’ focus in the middle of the week will shift to the newly-elected US President, Joe Biden’s, inauguration.…
-
Berenberg upgrades AJ Bell to ‘hold’
(Sharecast News) – Berenberg upgraded its stance on shares of investment platform AJ Bell on Tuesday to ‘hold’ from ‘sell’, hiking the…
-
Canaccord maintains ‘hold’ rating on Spirent Communications
(Sharecast News) – Analysts at Canaccord Genuity maintained their ‘hold’ rating on Spirent Communications on Tuesday following the group’s fourth-quarter trading update.…
-
Tuesday broker round-up
(Sharecast News) – AJ Bell: Berenberg upgrades to hold with a target price of 400p. BT Group: Berenberg reiterates buy with a…
-
Jefferies bullish on Indivior, says markets ‘too conservative’ on outlook for Sublocade
(Sharecast News) – Jefferies included drugs manufacturer Indivior on their latest quarterly list of 15 key buy ideas in the UK small…
-
Jefferies downgrades Wood Group, warns of likely revisions to revenue forecasts
(Sharecast News) – Jefferies has downgraded Wood Group ahead of potentially “significant” downward revisions to 2021 revenues. The bank cut its rating…
-
Credit Suisse downgrades Glaxo, highlights near-term challenges
(Sharecast News) – Credit Suisse downgraded GlaxoSmithKline to ‘underperform’ from ‘neutral’ on Wednesday, cutting the price target to 1,400p from 1,580p as…
Latest Publications
-
Why now is the time for fixed income | Wealth DFM 14 | October 2024
Featuring our exclusive interview with PIMCO’s Ryan Blute and Terry Oh Are you all set for what’s set to be…
IFA Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
